Data is currently not available. BioCryst Pharmaceuticals (BCRX) share price, charts, trades & the UK's most popular discussion forums. In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for $12.07/share. BioCryst Pharmaceuticals' stock is trading down $0.47 today. The brokerage presently has an "overweight" rating on the biotechnology company's stock. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.25) by ($0.09). BioCryst Pharmaceuticals, WKN: 896047, ISIN: US09058V1035 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen RBLX Stock Price: How High Will Roblox Stock Go? The company traded as high as $12.31 and last traded at $12.07. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. BioCryst Pharmaceuticals, Inc. Common Stock. And so with BCRX crossing above that average target price of $11.78/share, investors in BCRX have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $11.78 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? lll BioCryst Pharmaceuticals Chart Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. A number of brokerages have recently issued … BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. Ausführliches Aktienporträt der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de topaktuell! RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … $67.09. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. BioCryst Pharmaceuticals has a 52 week low of $1.58 and a 52 week high of $12.90. 14/03/2021 04:07:02 1 … You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. BioCryst to Host Virtual R&D Day on March 22, 2021 March 11, 2021 Early Access to BioCryst’s Berotralstat Granted for HAE Patients in France March 2, 2021 BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema BioCryst Pharmaceuticals Aktie - Hier finden Sie: BioCryst Pharmaceuticals Aktienkurs aktuell, Kurs, Chart und alle Kennzahlen für die BioCryst Pharmaceuticals Aktie. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. Free forex prices, toplists, indices and lots more. But the whole reason to look at the average BCRX price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. The two main areas that BioCrysts works in are the anti-viral space and the complement space. It has also been approved in Japan, Korea and China The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. (BCRX) Nasdaq Listed. Needham & Company LLC reaffirmed a hold rating on shares of BioCryst Pharmaceuticals in a research report on Wednesday, November 6th. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. ATX 3 158 0,3% DAX 14 502 -0,5% Dow 32 779 0,9% EStoxx50 3 833 -0,3% Nasdaq 12 937 -0,9% Öl 69,2 -0,6% Euro 1,1954 -0,3% CHF 1,1109 0,3% Gold 1 727 0,2% 58% zum Tageskurs der Aktie. As you can see below, BioCryst Pharmaceuticals had US$80.6m of debt, at June 2020, which is about the same as the year before. BNK Invest caters to investing firms and individual investors internationally. What Is BioCryst Pharmaceuticals's Net Debt? BioCryst Pharmaceuticals Aktie und BCRX Kursdiagramme. Type a symbol or company name. BioCryst Pharmaceuticals (NASDAQ: BCRX) is a mid-cap biotechnology company that is developing medications on two main areas of focus, and has one commercialized medications. $11.40. Below is a table showing the current thinking of the analysts that cover BioCryst Pharmaceuticals Inc: The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. And then on the other side of the spectrum one analyst has a target as high as $16.00. 80 M Aktien. Real-time exchange rate quote of BioCryst Pharmaceuticals, Inc. including detailed information, live chart and news, profile and other market data. These symbols will be available throughout the site during your session. Realtime-Chart und Realtime-Kurs für die BioCryst Pharmaceuticals Aktie auf BÖRSE ONLINE. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares, dropped in value on Thursday, Feb 04, with the stock price down by -6.31% to the previous day’s close as weak demand from buyers trailed the stock to $9.65. Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose 8.7% during mid-day trading on Tuesday . BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.67-4.97%: 12.81: 15:18:33: Open Price Low Price High Price Close Price Prev Close; 13.50: 12.63: 13.75: 13.48: Support 1 Support 2 Pivot Price Resistance 1 Resistance 2; 12.3767 : 11.9433 : 13.0633 : 13.4967 : 14.1833 : more quote information » BCRX Chart. Source: NASDAQ Stocks, Symbol: BioCryst Pharmaceuticals, Inc. 26-20:27 GMT. -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. Data is currently not available. -0.31 (-2.39%) DATA AS OF Mar 12, 2021 12:00 PM ET. Das Volumen addierte 8, 414, 830 Aktien, die mit dem durchschnittlichen Volumen von 8 verglichen werden. The Top 25 Broker Analyst Picks of the S&P 500 ». $11.095. Create your Watchlist to save your favorite quotes on Nasdaq.com. (NASDAQ: BCRX) Biocryst Pharmaceuticals currently has 176,565,622 outstanding shares. BIOCRYST PHARM (896047 | US09058V1035): Alle Börsen- und Handelsplätze mit aktuellen Kursen im Überblick. Kursdaten & Kursvergleich der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de kostenlos, realtime oder verzögert. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a … Nasdaq 100. Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. Hinweis. Nasdaq 100. Copy and paste multiple symbols separated by spaces. There are analysts with lower targets than the average, including one looking for a price of $7.00. Monthly Subscription. BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by stock analysts at JPMorgan Chase & Co. from $10.00 to $15.00 in a report issued on Wednesday, The Fly reports. How has BioCryst Pharmaceuticals's share price performed over time and what events caused price changes? BioCryst Pharmaceuticals Aktie: Hier finden Sie den BioCryst Pharmaceuticals Aktienkurs aktuell und ausserdem weitere Informationen wie den BioCryst Pharmaceuticals Chart The options have an exercise price of $7.45 per share, which is equal to the closing price of BioCryst common stock on the grant date. Instantly find out the BioCryst Pharmaceuticals, Inc. stock quote BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. The largest stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was held by Baker Bros. Advisors, which reported holding $21.9 million worth … RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … BioCryst Aktie (BCRX) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. With Biocryst Pharmaceuticals stock trading at $12.64 per share, the total value of Biocryst Pharmaceuticals stock (market capitalization) is $2.23B. At Stock Options Channel, our … Here's What to Do. The program will cover BioCryst’s unique, proven and prolific approach to developing oral medicines for rare diseases, with a focus on BCX9930, an oral … Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. Kostenlose Echtzeit-Kurse und aktive Aktienmarkt-Foren. Get the latest Zacks research report on BCRX — FREE. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. What Stifel Thinks, Cardano News: Coinbase Pro Adding ADA, 9 Things to Know Before Trading Begins March 18, The Week's Top Stories: Fed Effect, AstraZeneca, and March Madness, Professional Cornhole Makes Its Sports Betting Debut on DraftKings, SAFE Banking Act for Cannabis Industry Reintroduced in House, Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys, Lit Markets Provide Price Improvement Too, data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX — FREE, Top 25 Broker Analyst Picks of the S&P 500, Analyst target price data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX - FREE, Do Not Sell My Personal Information (CA Residents Only). $12.68. Copy and paste multiple symbols separated by spaces. Free forex prices, toplists, indices and lots more. The all time high for this statistics is 25. In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for … Technical analysis gauges display real-time ratings for the selected timeframes. Best Crypto Stocks To Buy Right Now As Bitcoin (BTC) Breached $60K? Type a symbol or company name. % danach wurde die Tagessitzung bei $ 4 geschlossen. BioCryst Pharmaceuticals, Inc. Common Stock, Do Not Sell My Personal Information (CA Residents Only). Latest Share Price and Events Stable Share Price : BCRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. The standard deviation is $3.153. Type a symbol or company name. Free forex prices, toplists, indices and lots more. Auf – – 2020 (Montag) Aktien von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) ergab einen Unterschied von 8. There are 9 different analyst targets contributing to that average for BioCryst Pharmaceuticals Inc, but the average is just that — a mathematical average. A number of other equities analysts also recently weighed in on the company. The biotechnology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.09). Free trial. At Stock Options Channel, our … BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was in 26 hedge funds' portfolios at the end of June. Approximately 6,345,274 shares changed hands during mid-day trading, a decline of 11% from the average daily volume of 7,123,782 shares. Handelsinformationen von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) BCRX ist sofort grün, wie dies heute im Intraday-Handel mit Aktion 1 zu sehen ist. The currently approved medication for BioCryst is peramivir, which we will discuss further in this piece. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. © 2021, Nasdaq, Inc. All Rights Reserved. BioCryst Pharmaceuticals Inc. Aktie aktuelle News Realtime Kurs & Chart Fundamentaldaten, Analysen & mehr - BioCryst Pharmaceuticals Inc. Aktie 896047, US09058V1035 Get BioCryst Pharmaceuticals Inc (BCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. $11.095. Call Option for BioCryst Pharmaceuticals Inc. BCRX#A1521E800000. BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. The summary for BIOCRYST PHARMACEUTICALS INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Biocryst Pharmaceuticals. lll BioCryst Pharmaceuticals PUSH-Chart | Push-Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Click here now. Get the latest BioCryst Pharmaceuticals, Inc. (BCRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. BioCryst Pharmaceuticals Reaches Analyst Target Price, Didn't Get Your Second Stimulus Check? When autocomplete results are available use up and down arrows to review and enter to select. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Data is currently not available. stock was originally listed at a price of $7.00 in Dec 31, 1997. Free forex prices, toplists, indices and lots more. BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today the pricing of an underwritten public offering of 18,711,113 shares of its common stock, offered at a price to the public of $4.50 per share. Create your Watchlist to save your favorite quotes on Nasdaq.com. 26. Der Sprung zu wöchentlichen Höchstständen von 4 US-Dollar. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. for only. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. 11/03/2021 00:22:52 1 … Type a symbol or company name. Nasdaq 100. Get the hottest stocks to trade every day before the market opens 100% free. BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. © 2021, Nasdaq, Inc. All Rights Reserved. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. This article used data provided by Zacks Investment Research via Quandl.com. Check the real-time BCRX stock price on the NASDAQ exchange and access historical data for BioCryst Pharmaceuticals, Inc. stock. Biocryst Pharmaceuticals Aktie (BCRX) Branche: : (WKN: 896047 ISIN: US09058V1035 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen. Results are available at a quick glance. The stock had previously closed at $11.10. Stay up to date with the latest discoveries, events, and reports from BioCryst. BidaskClub upgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) from a sell rating to a hold rating in a report issued on Wednesday morning, BidAskClub reports. BioCryst to Host Virtual R&D Day on March 22, 2021. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a virtual R&D day on Monday, March 22, 2021 from 9:00 am to 11:00 am ET. Add to Watchlist. %, der Ausblick über die letzten fünf Tage waren rot. Recently, BioCryst … Aktuelle Aktienkurse der BIOCRYST PHARMACEUTICALS INC, Börsenkurs 10,66 -6,61 %, Tief 10,660, Hoch 12,025 BioCryst (NASDAQ:BCRX) develops novel, oral and small molecules that inhibit enzymes playing a key role in biological pathways of rare diseases. The all time high for this statistics is 25. VAT not included. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). These symbols will be available throughout the site during your session. To short BioCryst Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th. BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.23-1.77%: 12.76: 00:00:07: Open Price Low Price High Price Close Price Prev Close; 12.87: 12.30: 13.16: 12.64: 12.99: more quote information » Recent News. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Unfall B293 Heute Bretten,
News In Erfurt,
Rücktritt Papst Benedikt Wikipedia,
The Undertaker Timothy Calaway,
Moodle Für Anfänger,
Ralph Caspers Mann,